Healio Gastroenterology Current Issue
The following articles appeared in the print edition of Healio Gastroenterology.
Table of Contents
- If not careful, NAFLD name change may damage decades of research on the disease Zobair M. Younossi, MD, MPH
-
- New name for NAFLD may not be better, process may become ‘endless debate’ Kenneth Cusi, MD, FACP, FACE
- Possible NAFLD name change must benefit both patients, field of hepatology Rohit Loomba, MD, MHSc
- To focus solely on NAFLD nomenclature, not patient care, is ‘ultimately detrimental’ Donna R. Cryer, JD
- Non-heavy alcohol use, total weekly consumption linked to fibrosis, NASH Kate Burba
- Targeted decision aids may not impact CRC screening preference among older adults Kate Burba
- FDA 2022 Rewind: GI drug pipeline rattles as FDA delivers 7 new drugs, 1 costly rejection Monica Stonehill
- Burning Rock secures FDA breakthrough device designation for multicancer blood test
- FDA agrees on Abivax’s pediatric study plan to develop obefazimod for children with IBD
-
- To reach consensus on NAFLD nomenclature, evaluation process must be democratic Stephen A. Harrison, MD, FAASLD
- ACG guides diagnosis, management of subepithelial GI lesions with new recommendations Kate Burba
- ACG updates guidance for celiac disease diagnosis, management in children, adults Kate Burba
- Curcumin-QingDai induces remission in active UC, ‘paves the way’ for integration in care Monica Stonehill
- Smartwatches, wearable technology ‘may hold promise’ to identify, predict IBD flare Robert Stott
- VIDEO: Evidence suggests it is safe to use preoperative biologics in IBD patients Kate Burba; Stefan D. Holubar, MD, MS
- CMS revises ambulatory payment classifications for transnasal endoscopy procedures
- Exact Sciences backs CMS policy update to waive cost-sharing for follow-up colonoscopy
-
- VIDEO: Healio Patient Voice winner breaks down barriers, promotes inclusive care Jacqueline Gaulin; Kate Burba